baber/WOPTO huggingface dataset:
Patent CA-2505265-C (CA)
Inventor: BOOKSTAFF BLAKE
IPC: H04M15/00
Filed: 2003-11-07
Granted: 2007-01-09
Abstract: La présente invention concerne un système et un procédé pour fournir à un ou plusieurs participants à un appel téléphonique, un(e) ou plusieurs publicités, services, études, et/ou offres de produits/de services, et/ou propositions visant à modifier l'ensemble de services téléphoniques souscrits ("actions d'interception" collectives). Une ou plusieurs publicités peuvent être fournies en un ou plusieurs instants d'un appel téléphonique qui aboutit ou non. Un ou plusieurs services peuvent être fournis gratuitement ou en échange de la présentation d'une ou de plusieurs publicités au destinataire du service. De plus, un ensemble de services téléphoniques souscrits associé à l'appelant ou à l'appelé peut être analysé et on peut proposer à l'appelant/à l'appelé l'option d'activer une ou plusieurs caractéristiques de service qui, au moment de l'appel, ne sont pas actives dans l'ensemble de services téléphoniques souscrits. Une étude peut être fournie à l'appelant/l'appelé et les réponses enregistrées. L'appelant/l'appelé peut également recevoir une offre de produits ou de services. Ces actions d'interception peuvent être mises en oeuvre en un instant quelconque de l'appel téléphonique, par ex. avant la composition du numéro, avant ou après un signal de ligne occupée ou la sonnerie du téléphone, après que l'une des personnes ait raccroché mais avant que l'autre/les autres personne(s) ai(en)t raccroché, et analogue.
Patent CA-2511982-C (CA)
Title: Control device of hybrid drive unit
Inventor: ENDO HIROATSU
IPC: B60L50/16
Filed: 2003-12-15
Granted: 2009-02-03
Abstract: A control device of a hybrid drive unit, wherein an assist prime mover is connected through a transmission to an output member, to which a torque outputted by a main prime mover is transmitted. The control device comprises a first torque correcting means for correcting the torque to be transmitted from the main prime mover to the output member during a gear shift by the transmission.
Patent CA-2514992-C (CA)
Inventor: EVANS GARY BRIAN
IPC: A61P31/04
Filed: 2004-01-30
Granted: 2012-08-07
Abstract: The present invention relates to a new process for the preparation of compounds of general formula (I) which are inhibitors of purine nucleoside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5'-methylthioadenosine phosphorylases (MTAP), 5'-methylthioadenosine nucleosidases (MTAN) and/or nucleoside hydrolases (NH).The present invention relates to a new process for the preparation of compounds of general formula (I) which are inhibitors of purine nucleoside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5'-methylthioadenosine phosphorylases (MTAP), 5'-methylthioadenosine nucleosidases (MTAN) and/or nucleoside hydrolases (NH).
Patent CA-2516575-C (CA)
Inventor: SCHLOSSER DEAN
IPC: F16L55/46
Filed: 2005-08-22
Granted: 2010-10-05
Abstract: Il s'agit d'un appareil qui pousse un racleur de double diamètre à travers un réducteur conique fixé à une gare à racleurs, et dans un pipeline, comprend une structure configurée de telle sorte que le racleur repose et avance sur la structure qui a une extrémité avant adaptée à la fixation à la gare. La position verticale de la structure peut être réglée pour aligner le racleur avec le réducteur conique. Un vérin est soutenu sur la structure vers l'arrière du racleur, et aligné avec lui, et une commande de vérin sort le vérin au contact de l'extrémité arrière d'un racleur et rentre également le vérin. Le vérin se verrouille sur la structure aux endroits de verrouillage espacés le long de la structure, et ces endroits de verrouillage sont séparés d'une distance inférieure à une course du vérin. Le racleur est poussé dans la gare par étapes, en sortant, rentrant et avançant le vérin à plusieurs reprises.
Patent CA-2516859-C (CA)
Title: Systems, devices, and methods for network wizards
Inventor: CORNETT JAMES W
IPC: H04L29/02
Filed: 2004-02-26
Granted: 2008-09-16
Abstract: Certain exemplary embodiments comprise a method for configuring a network interface device. The network interface device can be adaptable to connect a programmable logic controller to a network. The method can comprise automatically enforcing, via a wizard, user compliance with a plurality of predetermined steps for a computer-assisted configuration of the network interface device. The computer-assisted configuration of the network interface device can relate to an OSI transport layer or above. The method can comprise receiving at least one setting associated with a network connection for the network interface device
Patent CA-2524224-C (CA)
Inventor: FRUHAUF JOSEPH
IPC: H04B3/54
Filed: 2004-04-30
Granted: 2013-02-26
Abstract: The invention relates to a method for transmitting data over a carrier current using a frequency band. According to said method: the frequency band is divided into N sub-bands, N being a whole number higher than, or equal to, two; an OFDM (Orthogonal Frequency Division Multiplexing) technique is carried out on each of said sub-bands; and calculations are carried out based on each sub-band. The inventive method is characterised in that the calculations based on each sub-band are independent from the calculations based on the other sub-bands, and said sub-bands are dynamically activated and allocated. The invention also relates to modulation and demodulation devices for carrying out said method.
Patent CA-2525924-C (CA)
Title: Depigmenting agents
Inventor: GATTRELL WILLIAM THOMAS
IPC: C07C39/17
Filed: 2004-05-07
Granted: 2009-11-24
Abstract: The present invention is directed to crystalline forms of anhydrous 4-~cyclopentyl resorcinol, the Form A and C polymorphs, formulations containing at least one of these crystalline forms and their use to lighten skin.
Patent CA-2531155-C (CA)
Title: More compact and higher reliability power source system
Inventor: CASEY JEFFREY ALLEN
IPC: H02M3/00
Filed: 2005-02-18
Granted: 2008-07-22
Abstract: This invention features a more compact and higher reliability power source system for computing loads, the system including a high voltage DC bus connected to a number of DC sources each connected to the high voltage DC bus by a switch configured to deliver to the high voltage DC bus the DC source with the highest DC voltage, a low voltage DC bus connected to the computing loads, and a power supply including a number of DC/DC converters connected in parallel between the high voltage DC bus and the low voltage DC bus, and a controller configured to modulate each DC/DC converter to convert the high voltage on the high voltage DC bus to a low voltage output on the low voltage DC bus.
Patent CA-2541618-C (CA)
Title: Rsv polymerase inhibitors
Inventor: SIMONEAU BRUNO
IPC: A61P11/00
Filed: 2004-10-28
Granted: 2011-12-13
Abstract: Compounds or enantiomers of formula (I) or a salt thereof:  (see formula I) wherein R1, R2, R3, R4 and R5 are as defined herein, are useful for the manufacture of a medicament for the treatment or prevention of respiratory syncytial virus infection in a mammal.
Patent CA-2542763-C (CA)
Inventor: STAMM WERNER
IPC: A01N43/40
Filed: 2004-09-08
Granted: 2010-04-06
Abstract: The invention relates to a protective layer for the protection of a component against corrosion and oxidation at elevated temperatures. Previously known protective layers with a high Al and/or Cr content, which are additionally reinforced with Re, form brittle phases that embrittle further during use due to the influence of carbon. The inventive protective layer is composed of 0.5 to 2 percent rhenium, 24 to 26 percent cobalt, 15 to 21 percent chromium, 9 to 11.5 percent aluminum, 0.05 to 0.7 percent yttrium and/or at least one equivalent metal from the group comprising scandium and the rare earth elements, 0 to 1 percent ruthenium, the remainder consisting of cobalt and/or nickel and production-related impurities. Said protective layer is subject to hardly any embrittlement resulting from Cr/Re precipitations.
Patent CA-2545880-C (CA)
Inventor: ARNOLD STEFAN
IPC: A61K47/18
Filed: 2004-12-01
Granted: 2011-08-30
Abstract: A stable pharmaceutical formulation of erythropoietin is disclosed which contains tris-(hydroxymethyl)-aminomethane as stabilizer, whereby the formulation does not contain amino acids or human serumalbumin.
Patent CA-2549101-C (CA)
Inventor: ROSS RAYMOND S
IPC: A61F2/46
Filed: 2004-12-08
Granted: 2009-08-04
Abstract: A method for replacing a damaged spinal disc (10) between first and second vertebrae of a spinal column includes connecting a first mounting member (100) with the first vertebra of the spinal column. An artificial disc (10) is moved between the first and second vertebrae and into engagement with the first mounting member (100) to guide the artificial disc into position between the first and second vertebrae. The artificial disc includes a resilient core (90) having a first surface and a second surface, a first retaining member (20) connected to the first surface of the resilient core (90), and a second retaining member (60) connected to the second surface of the resilient core (90). The first retaining member (20) has an outer surface engageable with a first vertebra of the spinal column and an inner surface facing the first surface of the resilient core (90). The second retaining member (60) has an outer surface engageable with the second vertebra of the spinal column and an inner surface facing the second surface of the resilient core (90). An apparatus for replacing a damaged spinal disc in a spinal column includes a first retaining device (20) connected to the first surface of the resilient core (90). A second retaining device (60) is connected to the second surface of the resilient core (90). The second retaining device (60) has an outer surface engageable with a second vertebra and an inner surface facing the second surface of the resilient core (90). The inner surface of the first retaining device is spaced from the core (90). The core (90) deflects into engagement with the inner surface of the first retaining device (20) upon relative movement between the first and second retaining devices (20&60).
Patent CA-2554017-C (CA)
Title: Transient temperature control system and method for preventing destructive collisions in free piston machines
Inventor: UNGER REUVEN Z-M
IPC: F25B9/14
Filed: 2004-08-18
Granted: 2010-01-26
Abstract: The free piston cooler transient temperature control system of the present invention eliminates collisions during the transient cool-down period in a free piston cooler upon start-up. The transient temperature control system incorporates a free piston cooler, having a cold head and a warm end, a cold head temperature sensor, a relational interface, and a temperature controller.  The cold head temperature sensor senses the temperature of the cold head and generates a temperature signal. The relational interface is in communication with the temperature signal and contains a predetermined relationship between the cold head temperature and a maximum piston stroke during the transient cool-down temperature range. The relational interface generates a transient range maximum allowable stroke signal from the temperature signal and the predetermined relationship. The temperature controller is in communication with the relational interface and limits the piston stroke during the transient cool-down temperature range to prevent collisions.
Patent CA-2555345-C (CA)
Inventor: GUZI TIMOTHY J
IPC: A61K31/495
Filed: 2005-02-08
Granted: 2010-01-26
Abstract: Dans un bon nombre de modes de réalisation, on prévoit une nouvelle classe de composés pyrazolo[1,5-a]pyrimidine tenant lieu d'inhibiteurs de kinase dépendant de la cycline, des procédés de tels composés, de compositions pharmaceutiques contenant un ou plusieurs composés, de procédés de préparations de formulations pharmaceutiques comprenant un ou plusieurs des composés et des méthodes de traitement, de prévention, d'inhibition ou d'amélioration d'une ou plusieurs maladies associées aux CDK utilisant de tels composés ou compositions pharmaceutiques.
Patent CA-2556647-C (CA)
Inventor: TANAKA DON
IPC: A61M1/04
Filed: 2006-08-21
Granted: 2009-06-30
Abstract: A collateral ventilation bypass trap system directly linked with a patient's lung or lungs may be utilized to increase the expiratory flow from the diseased lung or lungs, thereby treating one aspect of chronic obstructive pulmonary disease. The system includes a trap, a filter/one-way valve and an air carrying conduit. The system also includes a retention device for securing system elements in position.
Patent CA-2558609-C (CA)
Inventor: STIREWALT DANIEL S
IPC: G06Q50/26
Filed: 2004-09-30
Granted: 2018-06-26
Abstract: Methods and systems are provided for creating and processing an electronic customs declaration manifest. These methods and systems include creating a image of the customs declaration form, converting the image of the customs declaration form into an electronic customs manifest, and transferring the electronic customs manifest to a database. In addition, a image is may also be forwarded electronically to a remote encoding center, where the customs declaration form data is manually converted into an electronic file for storing in a database. Customs services of both the originating and destination countries review the declared information stored in the database. When the international mailpiece arrives at the border, domestic customs service may find a matching unique identifiers on the international mailpieces and customs declaration forms stored in the database. The service provider may load an international mailpiece into an airplane, if a domestic customs service allow the international mailpiece having a matching unique identifier to leave the originating country. A service provider may return an international mailpiece to the domestic customs service if an international mailpiece is not allowed to leave the originating country.
Patent CA-2558880-C (CA)
Inventor: NAGAFUCHI NAOYUKI
IPC: H02B15/00
Filed: 2002-09-13
Granted: 2009-03-17
Abstract: Système et méthode de soutien à distance de l'exploitation d'une centrale électrique comportant les mécanismes suivants : a) transmission d'information; b) traitement d'information; c) déclenchement d'une tâche préparée de mesure corrective à prendre en cas d'anomalie. L'information peut comprendre les états de fonctionnement et les caractéristiques variables dans le temps des composants de la centrale. Des renseignements sur une mesure corrective à prendre en cas d'anomalie sont transmis à un gestionnaire de la centrale selon, par exemple, l'importance des difficultés techniques.
Patent CA-2562312-C (CA)
Inventor: KRELL ANTHONY
IPC: F24H9/20
Filed: 2006-10-03
Granted: 2009-12-22
Abstract: A water heater including a water reservoir container having a cold water inlet and a hot water outlet, a combustion chamber adjacent the water container, a burner associated with the container; a temperature probe associated with the container that detects a water temperature in an upper portion of the container, and a controller that activates the burner, the controller establishing an initial water temperature set point, comparing detected water temperature with the set point when the burner is activated, reducing the set point by a first selected amount when the water temperature decreases by less than a selected amount while the burner is activated or increasing the set point by a second selected amount when the water decreases by a selected amount of more while the burner is activated.
Patent CA-2562354-C (CA)
Title: Procede de synthese et intermediaires de benzoxathiepines
Inventor: VACHER BERNARD
IPC: C07C323/22
Filed: 2005-04-08
Granted: 2013-04-02
Abstract: L'invention concerne la préparation des dérivés de formule (1) (voir formule 1) dans laquelle notamment : R1 et R2, identiques ou différents, représentent un atome d'hydrogène, de fluor, de chlore, un groupe hydroxy, un radical alkyle, ou un radical alcoxy; R3 représente: un radical alkyle, un groupe hydroxy ou un radical méthoxy; R4 représente : un atome d'hydrogène ou un radical méthyle; et R5 et R6 identiques ou différents représentent: un atome d'hydrogène, un radical alkyle, un radical alcoxy, un radical alkylthio, ou un radical alkylamino, caractérisé en ce qu'il met en oeuvre la réduction d'un amide de formule (9) (voir formule 9)
Patent CA-2565962-C (CA)
Inventor: KIM HYANG KYUN
IPC: G02B6/02
Filed: 2005-05-06
Granted: 2014-03-11
Abstract: A photonic-bandgap fiber includes a photonic crystal lattice with a first material having a first refractive index and a pattern of a second material formed therein. The second material has a second refractive index lower than the first refractive index. The photonic crystal lattice has a plurality of first regions that support intensity lobes of the highest frequency bulk mode and has a plurality of second regions that do not support intensity lobes of the highest frequency bulk mode. The photonic-bandgap fiber further includes a central core formed in the photonic crystal lattice. The photonic-bandgap fiber further includes a core ring having an outer perimeter. The core ring surrounds the central core, wherein the outer perimeter of the core ring passes only through the second regions of the photonic crystal lattice.
Patent CA-2568820-C (CA)
Inventor: DUMITRU DAN
IPC: H04W4/12
Filed: 2006-11-23
Granted: 2014-11-04
Abstract: A method for downloading an attachment to an attachment viewer of a portable electronic device includes: sending an initial data request from the attachment viewer to a server in response to receipt of an email message including the attachment, building and storing a graph structure within the server representing a map of the attachment, encapsulating the graph structure in data having an attachment viewer readable format and sending an initial chunk of the data to the attachment viewer, the initial chunk of the data being stored on the portable electronic device. The initial chunk of the data is received by the portable electronic device prior to a request to view the attachment being selected by a user.
Patent CA-2571236-C (CA)
Title: Heat exchanger with header tubes
Inventor: COSTEN MICHAEL K
IPC: F28F3/00
Filed: 2005-06-20
Granted: 2012-08-14
Abstract: A heat exchange cell for use in a recuperator includes top and bottom plates spaced apart to define therebetween an internal space. Within the internal space are inlet and outlet header tubes communicating with a plurality of internal matrix fins. The header tubes are rigidly affixed to at least one adjacent header tube and to the top and bottom plates. The header tubes may have a rectangular cross-section and may, for example, be metallurgically bonded to the top and bottom plates and to each other through brazing. Rigidly affixing the header tubes to each other reduces the stress on the fillets that bond the tubes to the top and bottom plates. This in turn permits less structural material to be used in the header portions of the cell and reduces pressure drop across the headers.
Patent CA-2575782-C (CA)
Inventor: COHEN RICHMOND R
IPC: A61L15/46
Filed: 2005-07-19
Granted: 2014-07-15
Abstract: L'invention concerne des articles absorbants servant à retenir un fluide corporel malodorant. Les articles absorbants comprennent un additif, un sel d'ammonium quaternaire, soluble dans l'eau à 37 °C, qui contient une chaîne C16-C21 alkyle et comporte au moins deux atomes d'oxygène dans la partie anionique du sel. L'invention concerne aussi des procédés de préparation d'articles absorbants, y compris des articles absorbants jetables, qui contiennent ledit additif.
Patent CA-2577301-C (CA)
Inventor: BLUM CHARLES A
IPC: A61K31/506
Filed: 2005-08-13
Granted: 2014-05-27
Abstract: Substituted biaryl piperazinyl-pyridine analogues are provided, of the Formula (I): wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro,and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.
Patent CA-2579198-C (CA)
Inventor: STEPHENS THOMAS GLENN
IPC: F02B75/32
Filed: 2005-09-08
Granted: 2009-05-26
Abstract: A two-cycle swash plate internal combustion engine includes plural cylinders arranged about and having axes parallel to an output shaft. The output shaft includes a central axis having a fixed angular relationship to the central axes of the cylinders. A swash plate includes a first surface having a normal axis disposed at a first fixed angle to the central axis of the output shaft.  The swash plate is fixed to the output shaft. Reciprocating pistons disposed in the respective cylinders include connecting rods having followers secured to one end, respectively. The followers include surfaces engaged with a cooperating bearing surface on the swash plate.
Patent CA-2582703-C (CA)
Inventor: PREISS ASSAF
IPC: G06T3/00
Filed: 2007-03-20
Granted: 2012-09-04
Abstract: A computer-implemented method for image registration includes accepting a three-dimensional (3-D) image of an organ. The image includes a first plurality of image points with respective image coordinates. A map defining a distribution of values of a physiological parameter over the organ is accepted. The map includes a second plurality of map points with respective map coordinates. Confidence levels are associated with one or more of the map coordinates and image coordinates. Weights are assigned to at least some of the map points and image points responsively to the confidence levels of the respective map coordinates and image coordinates. The 3-D image is fitted with the map by calculating a geometrical transformation between the map coordinates and the image coordinates based on the weights.
Patent CA-2583983-C (CA)
Title: Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
Inventor: DRESCHER KARLA
IPC: C07D401/12
Filed: 2005-10-14
Granted: 2013-07-16
Abstract: The invention relates to compounds of the formula (I) wherein n is 0, 1 or 2;  G is CH2 or CHR3; R1 is H, C,-C6-alkyl, C,-C6-alkyl substituted by C3-C6-cycloalkyl, Cl-C6-hydroxyalkyl, fluorinated C,-C6-alkyl, C3-C6-cycloalkyl, fluorinated C3-C6-cycloalkyl, C3-C6~ alkenyl, fluorinated C3-C6-alkenyl, formyl, acetyl or propionyl; R2, R3 and R4 are, independently of each other, H, methyl, fluoromethyl, difluoromethyl, or trifluoromethyl; A is phenylene, pyridylene, pyrimidylene, pyrazinylene, pyridazinylene or thiophenylene, which can be substituted by one ore more substituents selected from halogen, methyl, methoxy and CF3; E is NR5 or CH2, wherein R5 is H or C1 -C3-alkyl; Ar is a cyclic radical selected from the group consisting of phenyl, a 5- or 6-~membered heteroaromatic radical comprising as ring members 1, 2 or 3 heteroatoms selected from N, O and S and a phenyl ring fused to a saturated or unsaturated 5- or 6-membered carbocyclic or heterocyclic ring, where the heterocyclic ring comprises as ring members 1, 2 or 3 heteroatoms selected from N, O and S and/or 1, 2 or 3 heteroatom-containing groups each independently selected from NR8, where R8 is H, C1-C4-alkyl, fluorinated C1-C4-alkyl, C1-C4~alkylcarbonyl or fluorinated C1-C4-alkylcarbonyl, and where the cyclic radical Ar may carry 1, 2 or 3 substituents Ra, wherein the variable Ra has the meanings given in the claims and in the description; and physiologically tolerated acid addition salts thereof. The invention also relates to the use of a compound of the formula I or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand.